Latest News About - single use devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, January 19, 2021

3:20:00 AM CET

Subscribe
RSS | MAP
Subscribe
subscribe | manage
Subscribe
current page | all pages
Subscribe
info | definition

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Thomas Burns said: “We are excited to announce this strong pivotal data highlighting the favorable safety and effectiveness of the iStent infinite . These data further underscore our view that iStent infinite may provide ophthalmic surgeons with a compelling new treatment alternative in a standalone procedure for patients with open-angle glaucoma uncontrolled by prior surgical or medical therapy,” External link

4-traders Wednesday, January 13, 2021 1:09:00 PM CET

Thomas Burns said: “I am extremely proud of our teams’ steadfast dedication and resiliency to advance our key strategic priorities and execute our plans while navigating the unique challenges associated with the COVID-19 pandemic over the course of 2020 into 2021. I also want to express my appreciation to our customers around the world who continue to prioritize serving the needs of patients,” External link

4-traders Wednesday, January 13, 2021 1:09:00 PM CET

Thomas Burns said: “These latest Phase 2 results further underscore the potential of iDose TR to safely provide multiple years of sustained glaucoma pharmaceutical therapy and tackle the significant problem of patient non-adherence to topical glaucoma medication regimens,” External link

4-traders Wednesday, January 13, 2021 1:09:00 PM CET

Santosh Singh said: “It is an honour to be working with HMD Ltd,” External link

direktbroker Tuesday, January 12, 2021 10:51:00 AM CET

Michael Friedrich said: “Dexter has already garnered tremendous interest in the surgical community and we look forward to answering the increasing demand for a medical device removing the complexity out of robotic surgery to fast track its widespread adoption in minimally invasive surgical care,” External link

medgadget Thursday, January 7, 2021 3:25:00 PM CET

Jim Joyce stated: “When we designed Sigyn Therapy, we envisioned a device that could be broadly deployed by the medical community, yet also have expansive first-in-industry capabilities that offer to improve patient outcomes,” External link

einnews Wednesday, January 6, 2021 5:33:00 PM CET

Michael Friedrich said: “In our view, the uptake of robotic systems will strongly increase with systems consciously designed for real-life clinical use, be that with regards to workflow integration, training, leveraging of existing equipment, openness to innovation as well as affordability,” External link

massdevice Wednesday, January 6, 2021 1:17:00 AM CET

Michael Friedrich said: “More than 60 surgical teams from Europe’s top hospitals have joined the validation studies at the various stages of the development of Dexter,” “It is together with those surgeons and nurses that we have refined Dexter, which is now ready for real-life clinical use” External link

massdevice Wednesday, January 6, 2021 1:17:00 AM CET

Rajiv Nath told: “We plan to increase manufacture to 80 crore (800 million) pieces per annum by the end of this month and then we will produce 100 crore (1 billion) pieces per annum in the second quarter of 2021 as India gets ready to roll-out the vaccine and 120 crore (1.2 billion) pieces per annum in July-August,” External link

asianage Monday, January 4, 2021 7:29:00 AM CET

Rajiv Nath said: “We bid to supply 22 crore (220 million) syringes from April to July-August against a tender of 35 crore (350 million) pieces sought by the government of India for 0.5 ml auto-disable syringes,” External link

asianage Monday, January 4, 2021 7:29:00 AM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.